Women’s Interests International Legal Developments Year in Review: 2024
August 13, 2025
By: Sandhya Taneja, Megan Dill, Nurhan I. Elgamil, Danielle D. Irvine, Isabella J. Schwarze, Cole Vick
Associates Sandhya Taneja, Danielle Irvine, Megan Dill, Nurhan Elgamil, Isabella Schwarze, and Cole Vick authored sections of the ABA International Law Section’s Year in Review for the Women’s Interest Network, with Sandhya also serving as the editor for the publication.
The review covers notable 2024 legal actions and developments in women’s representation in political leadership around the world, gender-based violence and discrimination, human trafficking, peace and security, and developments in International Criminal Courts and tribunals.
Notable international rulings include the ICC’s first ruling recognizing gender-based persecution as a crime against humanity in The Prosecutor v. Al Hassan, key ECHR cases on discrimination and violence against women, the EU’s Directive 2024/1385 criminalizing practices such as FGM, forced marriage, and cyber violence, and Sierra Leone’s Prohibition of Child Marriage Act imposing penalties on all who enable underage marriage.
The ABA Women’s Interest Network focuses on the advancement of legal rights and interests of women around the world through educational programs, teleconferences, policy initiatives, publications, communications, and outreach.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ABA White Collar Crime Institute 2026
Speaking Engagement
GCR Live Cartels: 2026
Speaking Engagement
Antitrust
Noerr Competition Day 2026
Speaking Engagement
Antitrust
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
University of Pennsylvania Journal of Business Law Annual Symposium 2026
Speaking Engagement
Antitrust
No More Needles in Haystacks: Congress Requires FDA to Explain Q1/Q2 Sameness
Axinn Viewpoints
Intellectual Property
Oliver Twisted Again: After FDA's Court Losses, Congress Approves FDA's Standards on Orphan Drug Exclusivity
Axinn Viewpoints
Intellectual Property
2025 Healthcare Antitrust Enforcement Wrap Up
Axinn Viewpoints
Antitrust
Here We Go Again: Third Round of Inflation Reduction Act Drugs Listed
Axinn Viewpoints
Intellectual Property